Inside Precision Medicine·3 min read·hard
FDA Approves First mRNA Flu Vaccine
H
Helen Albert
✦AI Summary
The FDA has approved Moderna's mFlusiva, the first mRNA-based influenza vaccine for adults aged 50 and older. This approval marks a significant milestone for mRNA technology beyond COVID-19 applications.
The FDA has approved Moderna’s influenza vaccine, mFlusiva, for use in adults aged 50 years and older after positive Phase III results in a trial of more than 40,000 people in this age group.
healthsciencetechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in